Karyopharm Therapeutics Inc. (KPTIQ) shareholders
KPTIQOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Ownership
Who owns Karyopharm Therapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 21 sales
Net sold $351.42K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Peter Kolchinsky Joint filing with RA Capital Management, L.P. (9.90%), Rajeev Shah (9.90%) and 1 more | 2,302,504 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| Rajeev Shah Joint filing with RA Capital Management, L.P. (9.90%), Peter Kolchinsky (9.90%) and 1 more | 2,078,913 | 9.90% | 13G (passive) | Mar 26, 2026 |
| Affinity Asset Advisors, LLC Joint filing with Michael Cho (8.60%) | 2,073,517 | 8.60% | 13G (passive) amendment | Mar 31, 2026 |
| Commodore Capital Master LP Joint filing with Commodore Capital LP (9.90%), Robert Egen Atkinson (9.90%) and 1 more | 1,950,000 | 9.90% | 13G (passive) | Mar 26, 2026 |
| Michael Cho Joint filing with Affinity Asset Advisors, LLC (8.60%) | 1,713,092 | 8.60% | 13G (passive) amendment | Jan 22, 2026 |
| Opaleye Management Inc. Joint filing with Opaleye, L.P. (9.48%), James Silverman (9.48%) | 1,569,002 | 9.48% | 13G (passive) | Oct 10, 2025 |
| T. Rowe Price Investment Management, Inc. | 1,539,147 | 6.60% | 13G (passive) amendment | May 31, 2026 |
| Robert Atchinson Joint filing with Adage Capital Management, L.P. (6.78%), Phillip Gross (6.78%) | 1,536,736 | 6.78% | 13G (passive) amendment | Jun 30, 2026 |
| Israel A. Englander Joint filing with Integrated Core Strategies (US) LLC (5.70%), Millennium Management LLC (5.70%) and 1 more | 1,297,297 | 5.70% | 13G (passive) | Aug 31, 2026 |
| BlackRock, Inc. | 1,266,084 | 5.60% | 13G (passive) | Jun 30, 2026 |
| Affinity Healthcare Fund, LP Joint filing with Affinity Asset Advisors, LLC (7.83%) | 664,224 | 7.83% | 13G (passive) | Apr 3, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Richard A. Paulson | President and CEO, Director | 269,747 | May 15, 2026 |
| Kristin Abate | Chief Accounting Officer | 18,616 | Oct 19, 2026 |
| Stuart Poulton | EVP, Chief Development Officer | 94,632 | Jul 30, 2026 |
| Reshma Rangwala | EVP & Chief Medical Officer | 56,829 | May 15, 2026 |
| Sohanya Roshan Cheng | EVP & Chief Commercial Officer | 107,940 | May 15, 2026 |
| Michael Mano | EVP, CLO&Secretary | 94,398 | May 15, 2026 |
| Lori Macomber | EVP, CFO & Treasurer | 85,105 | Feb 4, 2026 |
| Christy J. Oliger | Director | 15,508 | May 26, 2026 |
| Chen Schor | Director | 15,508 | May 26, 2026 |
| Barry E. Greene | Director | 16,415 | May 26, 2026 |
| Garen G. Bohlin | Director | 18,517 | May 26, 2026 |
| Deepika Pakianathan | Director | 15,508 | May 26, 2026 |
| Zhen Su | Director | 15,508 | May 26, 2026 |
| Mansoor Raza Mirza | Director | 17,121 | May 29, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kristin Abate Chief Accounting Officer | Oct 16, 2026 | Sale | −4,788 | $0.34 | $1.65K | 18,616 |
| Kristin Abate Chief Accounting Officer | Oct 1, 2026 | Sale | −378 | $1.19 | $450 | 23,404 |
| Kristin Abate Chief Accounting Officer | Sep 1, 2026 | Sale | −19 | $2.02 | $38 | 23,782 |
| Stuart Poulton EVP, Chief Development Officer | Jul 28, 2026 | Sale | −189 | $7.10 | $1.34K | 94,632 |
| Christy J. Oliger Director | May 21, 2026 | Award | +15,508 | – | – | 15,508 |
| Garen G. Bohlin Director | May 21, 2026 | Award | +15,508 | – | – | 18,517 |
| Zhen Su Director | May 21, 2026 | Award | +15,508 | – | – | 15,508 |
| Chen Schor Director | May 21, 2026 | Award | +15,508 | – | – | 15,508 |
| Deepika Pakianathan Director | May 21, 2026 | Award | +15,508 | – | – | 15,508 |
| Barry E. Greene Director | May 21, 2026 | Award | +15,508 | – | – | 16,415 |
| Stuart Poulton EVP, Chief Development Officer | May 14, 2026 | Sale | −403 | $9.50 | $3.83K | 94,821 |
| Kristin Abate Chief Accounting Officer | May 14, 2026 | Sale | −53 | $9.50 | $504 | 23,801 |
| Michael Mano EVP, CLO&Secretary | May 14, 2026 | Sale | −266 | $9.50 | $2.53K | 94,398 |
| Richard A. Paulson President and CEO, Director | May 14, 2026 | Sale | −2,203 | $9.50 | $20.93K | 269,747 |
| Reshma Rangwala EVP & Chief Medical Officer | May 14, 2026 | Sale | −408 | $9.50 | $3.88K | 56,829 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | May 14, 2026 | Sale | −324 | $9.50 | $3.08K | 107,940 |
| Stuart Poulton EVP, Chief Development Officer | May 13, 2026 | Award | +896 | – | – | 95,224 |
| Kristin Abate Chief Accounting Officer | May 13, 2026 | Award | +121 | – | – | 23,854 |
| Michael Mano EVP, CLO&Secretary | May 13, 2026 | Award | +700 | – | – | 94,664 |
| Richard A. Paulson President and CEO, Director | May 13, 2026 | Award | +4,920 | – | – | 271,950 |
| Reshma Rangwala EVP & Chief Medical Officer | May 13, 2026 | Award | +947 | – | – | 57,237 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | May 13, 2026 | Award | +947 | – | – | 108,264 |
| Reshma Rangwala EVP & Chief Medical Officer | Apr 21, 2026 | Sale | −449 | $8.94 | $4.01K | 56,290 |
| Stuart Poulton EVP, Chief Development Officer | Mar 2, 2026 | Sale | −5,101 | $9.41 | $48.00K | 94,328 |
| Kristin Abate Chief Accounting Officer | Mar 2, 2026 | Sale | −559 | $9.41 | $5.26K | 22,063 |
| Michael Mano EVP, CLO&Secretary | Mar 2, 2026 | Sale | −3,526 | $9.41 | $33.18K | 93,964 |
| Richard A. Paulson President and CEO, Director | Mar 2, 2026 | Sale | −12,361 | $9.41 | $116.32K | 267,030 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | Mar 2, 2026 | Sale | −4,604 | $9.41 | $43.32K | 107,317 |
| Reshma Rangwala EVP & Chief Medical Officer | Mar 2, 2026 | Sale | −5,066 | $9.41 | $47.67K | 56,739 |
| Stuart Poulton EVP, Chief Development Officer | Feb 17, 2026 | Sale | −378 | $8.63 | $3.26K | 99,429 |
| Richard A. Paulson President and CEO, Director | Feb 5, 2026 | Award | +81,060 | – | – | 279,391 |
| Lori Macomber EVP, CFO & Treasurer | Feb 3, 2026 | Sale | −1,626 | $6.30 | $10.24K | 85,105 |
| Lori Macomber EVP, CFO & Treasurer | Jan 31, 2026 | Award | +32,415 | – | – | 86,731 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | Jan 31, 2026 | Award | +32,415 | – | – | 111,921 |
| Michael Mano EVP, CLO&Secretary | Jan 31, 2026 | Award | +32,415 | – | – | 97,490 |
| Stuart Poulton EVP, Chief Development Officer | Jan 31, 2026 | Award | +32,415 | – | – | 99,807 |
| Reshma Rangwala EVP & Chief Medical Officer | Jan 31, 2026 | Award | +32,415 | – | – | 61,805 |
| Kristin Abate Chief Accounting Officer | Jan 28, 2026 | Sale | −50 | $7.03 | $352 | 22,622 |
| Kristin Abate Chief Accounting Officer | Jan 27, 2026 | Award | +92 | – | – | 22,672 |
| Kristin Abate Chief Accounting Officer | Jan 21, 2026 | Sale | −265 | $5.96 | $1.58K | 22,580 |
| Richard A. Paulson President and CEO, Director | Oct 15, 2025 | Award | +114,285 | – | – | 198,331 |
| Michael Mano SVP, General Counsel&Secretary | Oct 15, 2025 | Award | +43,650 | – | – | 65,075 |
| Lori Macomber EVP, CFO & Treasurer | Oct 15, 2025 | Award | +43,650 | – | – | 54,316 |
| Kristin Abate Chief Accounting Officer | Oct 15, 2025 | Award | +12,799 | – | – | 22,845 |
| Stuart Poulton EVP, Chief Development Officer | Oct 15, 2025 | Award | +39,682 | – | – | 67,392 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | Oct 15, 2025 | Award | +43,650 | – | – | 79,506 |
| Kristin Abate Chief Accounting Officer | Oct 1, 2025 | Sale | −362 | $6.30 | $2.28K | 10,046 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | Sep 15, 2025 | Sale | −325 | $6.43 | $2.09K | 35,856 |
| Richard A. Paulson President and CEO, Director | Sep 15, 2025 | Sale | −1,257 | $6.43 | $8.08K | 84,046 |
| Michael Mano SVP, General Counsel&Secretary | Sep 15, 2025 | Sale | −234 | $6.43 | $1.50K | 21,425 |
| Kristin Abate Chief Accounting Officer | Sep 15, 2025 | Sale | −23 | $6.43 | $148 | 10,408 |
| Stuart Poulton EVP, Chief Development Officer | Sep 15, 2025 | Sale | −401 | $6.43 | $2.58K | 27,710 |
| Reshma Rangwala EVP & Chief Medical Officer | Sep 15, 2025 | Sale | −408 | $6.43 | $2.62K | 29,390 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | Sep 12, 2025 | Award | +945 | – | – | 36,181 |
| Richard A. Paulson President and CEO, Director | Sep 12, 2025 | Award | +2,800 | – | – | 85,303 |
| Michael Mano SVP, General Counsel&Secretary | Sep 12, 2025 | Award | +612 | – | – | 21,659 |
| Kristin Abate Chief Accounting Officer | Sep 12, 2025 | Award | +46 | – | – | 10,431 |
| Stuart Poulton EVP, Chief Development Officer | Sep 12, 2025 | Award | +888 | – | – | 28,111 |
| Reshma Rangwala EVP & Chief Medical Officer | Sep 12, 2025 | Award | +945 | – | – | 29,798 |
| Kristin Abate Chief Accounting Officer | Sep 3, 2025 | Sale | −12 | $6.78 | $81 | 9,463 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
See a number that looks wrong?